Identification of distinct tumor cell populations and key genetic mechanisms through single cell sequencing in hepatoblastoma
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Sep 2021 · 1 min read
In brief
In brief
This study uses single-cell RNA sequencing to map cellular heterogeneity in hepatoblastoma, identifying distinct tumor cell populations and driver clusters that may explain chemoresistance. The research combines human tumor samples and patient-derived xenografts to reveal intratumor genetic expression patterns and signaling pathways that could inform novel targeted therapies for this pediatric liver malignancy.
Written by the GCMD Library team from the article.
Statements in this article
Hepatoblastoma is the most common primary liver malignancy of childhood.
Molecular investigations in hepatoblastoma are limited and effective treatment options for chemoresistant disease are lacking.
Single cell RNA sequencing analysis of human tumor, background liver, and patient derived xenograft demonstrates gene expression patterns within hepatoblastoma tumor and identifies intratumor cell subtype heterogeneity.
A driver tumor cell cluster in hepatoblastoma has been identified by genetic expression analysis.
Identification of critical mechanistic pathways combined with unique cell populations provides the basis for discovery and investigation of novel treatment strategies in vitro and in vivo for hepatoblastoma.